au.pereira
TL2 Moderator · Salvador
Contributes reviews on supplier material. Based in Salvador.
Joined 25 February 2025 · last posted 2d
80 posts, newest first. Showing up to 150.
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #102 · Data & Tools › Datasets · 26 Jul 2026 · 23 likes post #101 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Immortal time bias in a claims-database study — one year on Replied, post #37 · Evidence › Study critique · 22 Jul 2026 · 15 likes Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you think that affects the conclusion, maybe your criticism is…
-
How shortages have affected compounding permissions Replied, post #51 · Access › Shortages · 19 Jul 2026 · 10 likes International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is…
-
Deletion sequences: expected mass shifts by residue — the long version Replied, post #13 · Analytics › Impurities & related substances · 16 Jul 2026 · 16 likes I read post #11 twice before replying, because I had assumed the opposite. Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself…
-
What to bring: records that a clinician can actually use Replied, post #2 · Clinical › Prescriber conversations · 15 Jul 2026 · 3 likes Discussing off-label dosing: if you want to dose differently than the label specifies (slower titration, higher final dose), discussing that explicitly and…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #66 · Evidence › Journal club · 14 Jul 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #20 · Compounds › Cagrilintide & amylin analogues · 7 Jul 2026 · 1 like Picking up post #17: that is the part I would want checked first. Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms.…
-
How much context is too much context in a first post? Replied, post #10 · Start Here › How to Ask · 4 Jul 2026 · 11 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #35 · Compounds › Retatrutide · 3 Jul 2026 · 11 likes Coming back to post #33, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #97 · Analytics › HPLC & UHPLC · 2 Jul 2026 · 4 likes This follows post #94 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #128 · Practice › Reconstitution · 24 Jun 2026 · 0 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
Submitting a sample: the process end to end Replied, post #36 · Sourcing › Independent verification · 24 Jun 2026 · 6 likes Picking up post #33: that is the part I would want checked first. VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials.…
-
Revisiting: What pooling buys you and what it destroys Replied, post #57 · Evidence › Meta-analyses · 16 Jun 2026 · 10 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #22 · Compounds › Secretagogues & GH axis · 12 Jun 2026 · 12 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Historical amylin analogues and what happened to them Replied, post #18 · Compounds › Cagrilintide & amylin analogues · 11 Jun 2026 · 0 likes post #17 answers the question as asked. The question underneath it is different. Historical amylin analogues: pramlintide was the only long-acting amylin analogue…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #25 · Compounds › Secretagogues & GH axis · 6 Jun 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
When a dose reduction is the correct response to a side effect Replied, post #26 · Practice › Dosing & titration · 3 Jun 2026 · 5 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
Injecting into an area that has become firm: why not to Replied, post #8 · marked as the solution · Practice › Administration · 3 Jun 2026 · 8 likes Cold solution and stinging: warming the vial in your hands for a minute before injection reduces the stinging sensation substantially. This is the simplest thing to try…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #67 · Compounds › Tirzepatide · 19 May 2026 · 6 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #8 · Compounds › Secretagogues & GH axis · 19 May 2026 · 0 likes What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled, adequate sample size, IGF-1 as primary outcome, muscle and strength…
-
What a certificate commits its issuer to — the long version Replied, post #7 · Analytics › COA interpretation · 15 May 2026 · 0 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #9 · Analytics › COA interpretation · 29 Apr 2026 · 7 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #60 · Data & Tools › Calculators · 11 Apr 2026 · 14 likes Storage lookup: which conditions (temperature, time) are you considering storing in, and how much stability loss is expected? The calculator gives a rough estimate…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #31 · Practice › Administration · 15 Mar 2026 · 5 likes I read post #29 twice before replying, because I had assumed the opposite. Drawing up with one needle and injecting with another: a reasonable practice if you have…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #17 · Compounds › Repair & healing peptides · 9 Mar 2026 · 1 like The distinction between "no evidence it works" and "evidence it does not work": we have the first for these compounds. That is genuinely different from the second and…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #13 · Meta › Announcements · 7 Mar 2026 · 15 likes Archives: older announcements are archived by date. Checking archives is useful if you want to know what changed when.
-
Choosing which test to pay for, given a fixed budget Replied, post #9 · Sourcing › Independent verification · 28 Feb 2026 · 7 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
-
Coming back to: Time to steady state after a dose increase Replied, post #5 · Pharmacology › Pharmacokinetics · 24 Feb 2026 · 0 likes Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form and extends the half-life. Tirzepatide also has albumin binding…
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #20 · Clinical › Comorbidities · 19 Feb 2026 · 0 likes Coming back to post #18, because the follow-up matters more than the original answer. Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #77 · Outcomes › Progress reports · 18 Feb 2026 · 0 likes Exercise volume changes: increasing exercise intensity or duration can mask weight loss (muscle gain) on the scale. Noting exercise changes when reporting weight helps…
-
Preprint servers and what screening they do — the long version Started this topic · Evidence › Preprints · 15 Feb 2026 · 59 likes On the subject in the title: Preprint servers and what screening they do — the long version Working notes rather than a conclusion. Session topic: PIONEER 6 ( N Engl J…
-
The most common factual error about semaglutide on the internet — what changed since Replied, post #26 · Compounds › Semaglutide · 13 Feb 2026 · 11 likes Picking up post #23: that is the part I would want checked first. Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #77 · Pharmacology › Pharmacokinetics · 7 Feb 2026 · 7 likes Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #58 · Analytics › Method validation · 26 Jan 2026 · 4 likes Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above background. LOQ is the lowest concentration at which the method meets…
-
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #10 · Outcomes › Body composition · 24 Jan 2026 · 1 like Worth separating two things that post #6 runs together. Comparison to published data: the trials reported mean fat and lean mass changes. Individual results vary around…
-
Revisiting: Absolute versus relative contraindications Replied, post #11 · Safety › Contraindications · 20 Jan 2026 · 11 likes This follows post #8 rather than contradicting it. Diabetic retinopathy complications: a signal for this was noted in SUSTAIN 6. Current evidence is mixed. The risk is…
-
Prescription requirements and telehealth models Replied, post #82 · Sourcing › Regulatory · 21 Dec 2025 · 7 likes Why this category is maintained as documentation, not as recommendations: the goal is factual accuracy and sourcing, not endorsement of any specific regulatory position.
-
Early satiety becoming a problem rather than a benefit Replied, post #15 · Practice › Side effects · 12 Dec 2025 · 32 likes Picking up post #12: that is the part I would want checked first. Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other factors have…
-
Tracking that stops updating and then resumes — the long version Replied, post #48 · Sourcing › Logistics · 7 Dec 2025 · 6 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #28 · Access › Pricing · 2 Dec 2025 · 20 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Thyroid function tests during substantial weight change Replied, post #144 · Clinical › Bloodwork · 22 Nov 2025 · 31 likes Picking up post #141: that is the part I would want checked first. Biological variation: the person-to-person variation in a biomarker for a healthy person is larger…
-
Pen dose counters: what a click does and does not guarantee Replied, post #92 · Devices › Pens & autoinjectors · 18 Nov 2025 · 0 likes post #91 is right about the mechanism and I think understates the practical bit. Pen confusion between compounds: if you are using multiple pens or alternating pens,…
-
What pooling buys you and what it destroys Replied, post #65 · Evidence › Meta-analyses · 13 Nov 2025 · 3 likes Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate answers a question that no individual trial asked. High…
-
Reading SURMOUNT-1 without the press release Replied, post #54 · Compounds › Tirzepatide · 3 Nov 2025 · 20 likes post #53 is right about the mechanism and I think understates the practical bit. SURMOUNT-OSA is notable because it used an objective physiological endpoint, the…
-
Insurance and replacement policies, compared — the long version Replied, post #30 · Sourcing › Logistics · 23 Oct 2025 · 15 likes This follows post #27 rather than contradicting it. Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your personal use and…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #60 · Compounds › Other compounds · 1 Oct 2025 · 3 likes post #59 is right about the mechanism and I think understates the practical bit. This subcategory exists because some people will research compounds outside the main…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #91 · Data & Tools › Datasets · 9 Sep 2025 · 2 likes Community-collected datasets: some members have compiled datasets from their own experience and shared them. They are self-reported, unblinded, and therefore limited as…
-
Reading SURMOUNT-1 without the press release Replied, post #5 · Compounds › Tirzepatide · 9 Sep 2025 · 29 likes post #4 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
When to stop reading forums, including this one Replied, post #20 · Wellbeing › Mental health · 30 Aug 2025 · 4 likes Social and relationship impacts: weight change affects how others perceive and interact with a person. Those impacts are real and can be psychologically significant.
-
When a preprint is the best available evidence and we say so Replied, post #62 · Evidence › Preprints · 16 Aug 2025 · 22 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #104 · Compounds › Tirzepatide · 11 Aug 2025 · 11 likes Worth separating two things that post #100 runs together. SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not…
-
How to research a compound with no human data without deceiving yourself Replied, post #99 · Compounds › Other compounds · 4 Aug 2025 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #66 · Sourcing › Regulatory · 1 Aug 2025 · 0 likes On post #62 — agreed on the reasoning, with one qualification. Research-use-only status is a legal classification, not a safety classification. It means the compound is…
-
Food effects on oral incretin absorption: what is documented Replied, post #3 · marked as the solution · Compounds › Oral incretins · 22 Jul 2025 · 29 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #49 · Data & Tools › Calculators · 12 Jul 2025 · 16 likes Units: all calculators explicitly require units to be stated. This prevents the decimal-point errors that come from forgetting units. Always verify units in and out.
-
Repeatability versus intermediate precision Replied, post #134 · Analytics › Method validation · 3 Jul 2025 · 3 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #44 · Compounds › Repair & healing peptides · 19 Jun 2025 · 23 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #100 · Compounds › Tirzepatide · 2 Jun 2025 · 0 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #34 · Compounds › Oral incretins · 19 May 2025 · 31 likes post #33 is right about the mechanism and I think understates the practical bit. Why an oral formulation is a formulation achievement: the molecule is the same but the…
-
Follow-up: Documentation that appears only after payment Replied, post #59 · Sourcing › Red flags · 9 May 2025 · 0 likes Coming back to post #57, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #44 · Compounds › Secretagogues & GH axis · 17 Apr 2025 · 25 likes IGF-1 as a surrogate: it is a better integrated measure than a spot growth hormone level and it is still a surrogate, with all the caveats that come with surrogates.…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #15 · Data & Tools › Calculators · 13 Apr 2025 · 2 likes I read post #13 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Reading an MS report that only gives you a single number Replied, post #51 · Analytics › Mass spectrometry · 12 Apr 2025 · 24 likes Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can suppress the peptide signal. Clean samples give higher…
-
A certificate with no method stated: what can you conclude? Replied, post #49 · Analytics › COA interpretation · 9 Apr 2025 · 16 likes I read post #47 twice before replying, because I had assumed the opposite. A certificate of analysis is a statement by its issuer that a defined test was performed on a…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #120 · Sourcing › Regulatory · 3 Apr 2025 · 0 likes Approval versus licensing: a compound can be approved for a specific indication in one country and not approved at all in another. Tracking jurisdictional approval is…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #45 · Analytics › Mass spectrometry · 25 Mar 2025 · 9 likes I read post #43 twice before replying, because I had assumed the opposite. Resolution: "high resolution" commonly means
-
Validating a method you did not develop — does this still hold? Replied, post #21 · Analytics › Method validation · 18 Feb 2025 · 17 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
What we do not know about retatrutide, listed explicitly Replied, post #81 · Compounds › Retatrutide · 3 Feb 2025 · 4 likes On post #77 — agreed on the reasoning, with one qualification. Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only…
-
Protein density versus volume when you cannot eat much Replied, post #45 · Nutrition & Training › Protein & intake · 31 Jan 2025 · 0 likes Picking up post #42: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Recovery when intake is low: what to cut first Replied, post #63 · Nutrition & Training › Resistance training · 13 Jan 2025 · 0 likes I read post #61 twice before replying, because I had assumed the opposite. Adaptation and plateau: if strength does not change for weeks, that is stability, not…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #75 · Compounds › Semaglutide · 23 Dec 2024 · 31 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
The topic list is dense — is that deliberate? Replied, post #70 · Meta › Site feedback · 21 Dec 2024 · 1 like I read post #68 twice before replying, because I had assumed the opposite. Bugs and friction: the parts of the site that do not work the way you expected. Report them…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #77 · Access › Insurance & coverage · 19 Dec 2024 · 18 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #155 · Analytics › COA interpretation · 17 Dec 2024 · 0 likes I read post #153 twice before replying, because I had assumed the opposite. Reading old certificates: if a certificate is dated years ago, the lot it describes might be…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #69 · Compounds › Tirzepatide · 2 Dec 2024 · 0 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
-
Revisiting: Moderation log format change Replied, post #48 · Meta › Announcements · 30 Nov 2024 · 30 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Why quantitation is the hard part, not detection Started this topic · Analytics › Home & field testing · 8 Nov 2024 · 12 likes Why quantitation is the hard part, not detection I have a specific reason for asking rather than idle curiosity, and the context is below. Posting the method first,…
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #16 · Sourcing › Regulatory · 29 Oct 2024 · 30 likes I read post #14 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #17 · Clinical › Bloodwork · 8 Sep 2024 · 0 likes Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #9 · Compounds › Retatrutide · 16 Jul 2024 · 0 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…